Production of protective human antipneumococcal antibodies by transgenic mice with human immunoglobulin loci

Nina D. Russell, Jose R F Corvalan, Michael L. Gallo, C. Geoffrey Davis, Liise-anne Pirofski

Research output: Contribution to journalArticle

36 Citations (Scopus)

Abstract

Infections with Streptococcus pneumoniae remain a significant cause of morbidity and mortality. To gain insight into structure-function relationships for human antibodies to pneumococcal capsular polysaccharide (PPS), we studied the response of transgenic mice reconstituted with human immunoglobulin loci, XenoMouse, to PPS antigens in a pneumococcal vaccine. Enzyme-linked immunosorbent assays of sera from mice vaccinated with a 23- valent pneumococcal vaccine revealed that they produced serotype-specific human antibodies, with the greatest response being to the PPS of serotype 3 (PPS 3). Molecular sequence analysis of three monoclonal antibodies (MAbs) to PPS 3 generated from lymphoid cells from mice vaccinated with a 23-valent pneumococcal vaccine or a PPS 3-bovine serum albumin conjugate revealed that they all used heavy-chain immunoglobulin genes from the V(H)3 family, two expressed light chain genes from the human Vκ1 family, and one expressed a mouse λ light chain. The protective efficacy of the two MAbs was examined in mice. A 10-μg dose of both, and a 1-μg dose of one, significantly prolonged survival from a lethal serotype 3 infection in CBA/N mice. Our data show that XenoMouse mice produced protective, serotype-specific human antibodies to PPS 3, and they lend support to the proposal that these animals represent a useful model to study the human antibody response to PPS antigens.

Original languageEnglish (US)
Pages (from-to)1820-1826
Number of pages7
JournalInfection and Immunity
Volume68
Issue number4
DOIs
StatePublished - Apr 2000

Fingerprint

Transgenic Mice
Polysaccharides
Immunoglobulins
Antibodies
Pneumococcal Vaccines
Monoclonal Antibodies
Immunoglobulin Variable Region
Pneumococcal Infections
Light
Antigens
Immunoglobulin Heavy Chains
Inbred CBA Mouse
Bovine Serum Albumin
Antibody Formation
Sequence Analysis
Enzyme-Linked Immunosorbent Assay
Lymphocytes
Morbidity
Survival
Mortality

ASJC Scopus subject areas

  • Immunology

Cite this

Production of protective human antipneumococcal antibodies by transgenic mice with human immunoglobulin loci. / Russell, Nina D.; Corvalan, Jose R F; Gallo, Michael L.; Davis, C. Geoffrey; Pirofski, Liise-anne.

In: Infection and Immunity, Vol. 68, No. 4, 04.2000, p. 1820-1826.

Research output: Contribution to journalArticle

Russell, Nina D. ; Corvalan, Jose R F ; Gallo, Michael L. ; Davis, C. Geoffrey ; Pirofski, Liise-anne. / Production of protective human antipneumococcal antibodies by transgenic mice with human immunoglobulin loci. In: Infection and Immunity. 2000 ; Vol. 68, No. 4. pp. 1820-1826.
@article{835fa21eb51a4483a4e77a4cdb563e2b,
title = "Production of protective human antipneumococcal antibodies by transgenic mice with human immunoglobulin loci",
abstract = "Infections with Streptococcus pneumoniae remain a significant cause of morbidity and mortality. To gain insight into structure-function relationships for human antibodies to pneumococcal capsular polysaccharide (PPS), we studied the response of transgenic mice reconstituted with human immunoglobulin loci, XenoMouse, to PPS antigens in a pneumococcal vaccine. Enzyme-linked immunosorbent assays of sera from mice vaccinated with a 23- valent pneumococcal vaccine revealed that they produced serotype-specific human antibodies, with the greatest response being to the PPS of serotype 3 (PPS 3). Molecular sequence analysis of three monoclonal antibodies (MAbs) to PPS 3 generated from lymphoid cells from mice vaccinated with a 23-valent pneumococcal vaccine or a PPS 3-bovine serum albumin conjugate revealed that they all used heavy-chain immunoglobulin genes from the V(H)3 family, two expressed light chain genes from the human Vκ1 family, and one expressed a mouse λ light chain. The protective efficacy of the two MAbs was examined in mice. A 10-μg dose of both, and a 1-μg dose of one, significantly prolonged survival from a lethal serotype 3 infection in CBA/N mice. Our data show that XenoMouse mice produced protective, serotype-specific human antibodies to PPS 3, and they lend support to the proposal that these animals represent a useful model to study the human antibody response to PPS antigens.",
author = "Russell, {Nina D.} and Corvalan, {Jose R F} and Gallo, {Michael L.} and Davis, {C. Geoffrey} and Liise-anne Pirofski",
year = "2000",
month = "4",
doi = "10.1128/IAI.68.4.1820-1826.2000",
language = "English (US)",
volume = "68",
pages = "1820--1826",
journal = "Infection and Immunity",
issn = "0019-9567",
publisher = "American Society for Microbiology",
number = "4",

}

TY - JOUR

T1 - Production of protective human antipneumococcal antibodies by transgenic mice with human immunoglobulin loci

AU - Russell, Nina D.

AU - Corvalan, Jose R F

AU - Gallo, Michael L.

AU - Davis, C. Geoffrey

AU - Pirofski, Liise-anne

PY - 2000/4

Y1 - 2000/4

N2 - Infections with Streptococcus pneumoniae remain a significant cause of morbidity and mortality. To gain insight into structure-function relationships for human antibodies to pneumococcal capsular polysaccharide (PPS), we studied the response of transgenic mice reconstituted with human immunoglobulin loci, XenoMouse, to PPS antigens in a pneumococcal vaccine. Enzyme-linked immunosorbent assays of sera from mice vaccinated with a 23- valent pneumococcal vaccine revealed that they produced serotype-specific human antibodies, with the greatest response being to the PPS of serotype 3 (PPS 3). Molecular sequence analysis of three monoclonal antibodies (MAbs) to PPS 3 generated from lymphoid cells from mice vaccinated with a 23-valent pneumococcal vaccine or a PPS 3-bovine serum albumin conjugate revealed that they all used heavy-chain immunoglobulin genes from the V(H)3 family, two expressed light chain genes from the human Vκ1 family, and one expressed a mouse λ light chain. The protective efficacy of the two MAbs was examined in mice. A 10-μg dose of both, and a 1-μg dose of one, significantly prolonged survival from a lethal serotype 3 infection in CBA/N mice. Our data show that XenoMouse mice produced protective, serotype-specific human antibodies to PPS 3, and they lend support to the proposal that these animals represent a useful model to study the human antibody response to PPS antigens.

AB - Infections with Streptococcus pneumoniae remain a significant cause of morbidity and mortality. To gain insight into structure-function relationships for human antibodies to pneumococcal capsular polysaccharide (PPS), we studied the response of transgenic mice reconstituted with human immunoglobulin loci, XenoMouse, to PPS antigens in a pneumococcal vaccine. Enzyme-linked immunosorbent assays of sera from mice vaccinated with a 23- valent pneumococcal vaccine revealed that they produced serotype-specific human antibodies, with the greatest response being to the PPS of serotype 3 (PPS 3). Molecular sequence analysis of three monoclonal antibodies (MAbs) to PPS 3 generated from lymphoid cells from mice vaccinated with a 23-valent pneumococcal vaccine or a PPS 3-bovine serum albumin conjugate revealed that they all used heavy-chain immunoglobulin genes from the V(H)3 family, two expressed light chain genes from the human Vκ1 family, and one expressed a mouse λ light chain. The protective efficacy of the two MAbs was examined in mice. A 10-μg dose of both, and a 1-μg dose of one, significantly prolonged survival from a lethal serotype 3 infection in CBA/N mice. Our data show that XenoMouse mice produced protective, serotype-specific human antibodies to PPS 3, and they lend support to the proposal that these animals represent a useful model to study the human antibody response to PPS antigens.

UR - http://www.scopus.com/inward/record.url?scp=0034018855&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034018855&partnerID=8YFLogxK

U2 - 10.1128/IAI.68.4.1820-1826.2000

DO - 10.1128/IAI.68.4.1820-1826.2000

M3 - Article

C2 - 10722569

AN - SCOPUS:0034018855

VL - 68

SP - 1820

EP - 1826

JO - Infection and Immunity

JF - Infection and Immunity

SN - 0019-9567

IS - 4

ER -